Decoder with Nilay Patel
How Philips CEO Roy Jakobs is turning the company around after major recall
Roy Jakobs
Yes, because there's a distinct difference between we have delivered safe products to the market, but what the FDA acted on is the processes to deliver these products were not followed as per the standards that the FDA would like us to follow them. So that there were deviations found in the process that was kind of coming out of the engagement with the FDA.
0
💬
0
Comments
Log in to comment.
There are no comments yet.